{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:54:57Z","timestamp":1769529297761,"version":"3.49.0"},"reference-count":11,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T00:00:00Z","timestamp":1294704000000},"content-version":"vor","delay-in-days":9506,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[1985,1]]},"abstract":"<jats:p><jats:bold>Abstract. <\/jats:bold> In a double\u2010blind randomized controlled study of 300 women, 150 primiparas and 150 multiparas, induction of labor by means of vaginal suppositories containing 3 mg prostaglandin E<jats:sub>2<\/jats:sub> (PGE<jats:sub>2<\/jats:sub>) was compared with the conventional method of intranasal oxytocin and with a combined method of 3 mg PGE<jats:sub>2<\/jats:sub> vaginal suppositories alternating with intranasal oxytocin. In the PGE<jats:sub>2<\/jats:sub> group the intensity of delivery was significantly greater than in the oxytocin group, among both primiparas and multiparas and among the patients with ripe and unripe cervix. The efficiency of the combined treatment could no be evaluated because of the high intensity of delivery during the first 24 hours. There were no maternal side effects, and no significant difference in the frequencies of failed induction and cesarean section.<\/jats:p>","DOI":"10.3109\/00016348509154710","type":"journal-article","created":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T17:57:36Z","timestamp":1260295056000},"page":"157-161","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["INDUCTION OF LABOR"],"prefix":"10.1111","volume":"64","author":[{"given":"B.","family":"Andreasson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes E.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,11]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"266","article-title":"Pelvic scoring for elective induction","volume":"24","author":"Bishop E H.","year":"1964","journal-title":"Ob-stet Gynecol"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1971.tb08611.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1982.tb05094.x"},{"key":"e_1_2_1_5_1","first-page":"2227","article-title":"Igangs\u00e6t\u2010telse af f\u00f8dsel med prostaglandin E2 vagitorier","volume":"143","author":"Larsen J.","year":"1981","journal-title":"Ugeskr L\u00e6ger"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)32584-4"},{"issue":"9","key":"e_1_2_1_7_1","first-page":"59","article-title":"Induction of labor. A comparison of intravenous, intranasal and transbuccal oxytocin","author":"M\u00fcller K.","year":"1967","journal-title":"Acta Obstet Gynecol Scand"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91004-3"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6182.108"},{"key":"e_1_2_1_11_1","first-page":"596","article-title":"Prostaglandin vaginal suppositories: a simple and safe approach to the induction of labour","volume":"58","author":"Shepherd J H.","year":"1981","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_12_1","first-page":"581","article-title":"Prostaglandin E2 intracervically versus oxytocin intravenously for ripening of uterine cervix and\/or induction of labor in patients at term","volume":"54","author":"Ulmsten U.","year":"1979","journal-title":"Obstet Gynecol"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.3109%2F00016348509154710","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.3109\/00016348509154710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T06:54:17Z","timestamp":1697784857000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.3109\/00016348509154710"}},"subtitle":["A double\u2010blind randomized controlled study of prostaglandin E2 vaginal suppositories compared with intranasal oxytocin and with sequential treatment"],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["10.3109\/00016348509154710"],"URL":"https:\/\/doi.org\/10.3109\/00016348509154710","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]},"assertion":[{"value":"2011-01-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}